2026 NPPES data Hematology & Oncology Physician NPI 1124391727 M.D.
Verify on CMS →

ANURAG SHARMA, M.D.

Hematology & Oncology Physician in FARMINGTON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
465
Medicare Part D claims · 122 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
What the federal data reveals: ANURAG SHARMA, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in FARMINGTON, Connecticut with a Medicare Part D prescribing footprint of 465 claims across 122 beneficiaries — 17% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: ANURAG SHARMA, M.D. reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 465 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ANURAG SHARMA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ANURAG SHARMA, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 02/14/2012

NPI 1124391727

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

465 45% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Connecticut

How Hematology & Oncology Physician compares to other specialties among Connecticut providers

Connecticut providers

Hematology & Oncology Physician share within Connecticut

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Connecticut

Medicare quality performance — MIPS

ANURAG SHARMA, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Hematology & Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANURAG SHARMA, M.D. is a Hematology & Oncology Physician provider practicing in FARMINGTON, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1124391727. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANURAG SHARMA, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 263 FARMINGTON AVE, FARMINGTON, CT, 06032, with a listed phone of (860) 679-2000. NPI 1124391727 was issued on 02/14/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHARMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 465 prescription claims written by this provider, covering 122 Medicare beneficiaries and totaling roughly $862K in drug spend, split 17% brand-name and 83% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8066), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

263 FARMINGTON AVE
FARMINGTON, CT 06032

Provider Details

NPI 1124391727
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 02/14/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
86.8066
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where ANURAG SHARMA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
SMITHTOWN, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

ANURAG SHARMA, M.D. — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 465 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

465
Total Claims
$862K
Total Drug Cost
122
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
877
Total Day Supply
25,295
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$818K
Generic Drug Cost
$45K

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.76
Gender Split
91% female / 9% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
174
Letrozole
39
Ibrance
Palbociclib
25
Hydroxyurea
21
Eliquis
Apixaban
16
Prednisone
12
Tamoxifen Citrate
11
Xarelto
Rivaroxaban
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How ANURAG SHARMA, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

ANURAG SHARMA, M.D.'s 465 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as SHARMA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANURAG SHARMA, M.D.'s specialty?
ANURAG SHARMA, M.D. specializes in Hematology & Oncology Physician and practices in FARMINGTON, Connecticut. Credentials: M.D..
How much does ANURAG SHARMA, M.D. prescribe under Medicare Part D?
In 2023, ANURAG SHARMA, M.D. wrote 465 Medicare Part D claims totaling $862K in drug costs for 122 beneficiaries.
What is ANURAG SHARMA, M.D.'s Medicare quality score?
ANURAG SHARMA, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 86.8066). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANURAG SHARMA, M.D. located?
ANURAG SHARMA, M.D. is located at 263 FARMINGTON AVE, FARMINGTON, CT, 06032. Phone: (860) 679-2000.
What is ANURAG SHARMA, M.D.'s NPI number?
ANURAG SHARMA, M.D.'s National Provider Identifier (NPI) is 1124391727, issued on 02/14/2012.
Does ANURAG SHARMA, M.D. prescribe more brand-name or generic drugs?
ANURAG SHARMA, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $818K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does ANURAG SHARMA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ANURAG SHARMA, M.D.'s most frequently prescribed drugs include Anastrozole, Letrozole, Ibrance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANURAG SHARMA, M.D. accept Medicare?
ANURAG SHARMA, M.D. appears in CMS Medicare data with 465 Part D claims and 122 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANURAG SHARMA, M.D.'s credentials?
ANURAG SHARMA, M.D.'s NPI is 1124391727 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology